FDA MAP
  • Home
  • Training
    • WORKSHOPS
    • WEBINARS
    • CUSTOM TRAINING
  • SERVICES
    • REGULATORY SERVICES
    • FDA AUDITING
    • QUALITY ASSURANCE
    • CLINICAL TRIAL SERVICES
  • News Releases
  • About Us
Newsletter - January 28, 2016

Drug Pricing Debates Get Politicized in the Wrong Way

This week Presidential contender Senator Bernie Sanders announced that he would block Dr. Robert Califf’s nomination to lead FDA due to his “lack of commitment to lowering drug prices”. Doing this he joins Senator Markey who opposed Califf for approving opiates, and Senator Murkowski who is opposed due to labeling of genetically modified salmon. However, Mr. Sander’s opposition seems to be the most egregious. Read More..
 
Journals to Require Clinical Trial Data Sharing for Publishing Articles

Clinical trial transparency has been a contentious issue between sponsors of trials wanting to protect their assets, and the other stakeholders, such as trial participants, demanding increased rapid disclosure. Per the clinical trial disclosure laws written in 2007, all clinical trials must be registered and their data published on clinicaltrials.gov. However, the quality of data published on clinicaltrials.gov web-site leaves a lot to be desired.  Read More..


Our Services

  • Workshops
  • Webinars
  • On-Demand Webinars
  • Custom training
  • Training Subscriptions
  • Corporate Registration
  • Certification Program
  • Smart Recruitment
  • Corporate Registration - Online Workshop​

Company

  • About Us​
  • Testimonials
  • Free Resources
  • Newsletter
  • Videos (Free Tutorials)

Support

  • Contact Us
  • Terms of Service
  • Privacy Policy
  • News Archive
Consultation Service
FDA Training Company
Copyright © 2022 FDAMap.com
Use of this Web site constitutes acceptance of the FDAMap Terms of Use and Privacy Policy.